Schenkel
PersonRelationship Network
HOUSE_OVERSIGHT_024921.jpg
This document is page 105 of a 'Cowen Collaborative Insights' report dated February 25, 2019. It serves as a 'Points of Contact' directory listing the profiles, contact information, and coverage areas for eleven Cowen research analysts. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024921', indicating it was produced during a House Oversight Committee investigation.
HOUSE_OVERSIGHT_024838.jpg
This document is page 22 of a Cowen 'Collaborative Insights' market research report dated February 25, 2019, specifically analyzing 'Life Science Tools Participation In The Legal Cannabis Market.' It details the specific scientific technologies (such as Liquid Chromatography and Mass Spectrometry) used for testing cannabis potency and contaminants (pesticides, heavy metals, etc.). The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was produced as part of a congressional investigation, though the text itself contains no direct references to Jeffrey Epstein.
HOUSE_OVERSIGHT_024833.jpg
This document is page 17 of a financial research report produced by Cowen and Company, dated February 25, 2019. The content focuses on 'Synthetic Cannabis,' detailing the differences between endogenous, phyto-, and synthetic cannabinoids, and includes a table (Figure 9) outlining the medicinal roles of specific compounds like THC and CBD. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production for a congressional investigation, the visible text contains no direct references to Jeffrey Epstein or his associates.
HOUSE_OVERSIGHT_024823.jpg
This document is page 7 of a financial research report titled 'Cowen's Collective View of CBD,' dated February 25, 2019. It outlines the anticipated growth of the U.S. CBD market to $16 billion by 2025 and lists various analysts covering specific sectors such as consumer products, pharmacy, and regulation. The document bears a 'HOUSE_OVERSIGHT' stamp, indicating it was likely produced as part of a congressional investigation, possibly related to banking records, though the text itself contains no direct references to Jeffrey Epstein.
HOUSE_OVERSIGHT_024822.jpg
This document is the Table of Contents for a 'Cowen Collaborative Insights' research report dated February 25, 2019, focusing on the CBD and Cannabis market. The report covers various sectors including consumer products, healthcare, and global landscapes, with sections attributed to specific analysts (e.g., Azer, Nadeau, Schenkel). The document bears a 'HOUSE_OVERSIGHT_024822' Bates stamp, indicating it is part of a document production to the House Oversight Committee, likely related to investigations into financial records.
HOUSE_OVERSIGHT_024820.jpg
This document is page 4 of a Cowen 'Collaborative Insights' market research report dated February 25, 2019. It analyzes the market for cannabinoids (CBD), focusing on synthetic biology production methods, laboratory testing opportunities for life science companies, and the perspectives of drug retailers and insurance payors regarding coverage and sales. The document bears a 'HOUSE_OVERSIGHT_024820' Bates stamp, indicating it was part of a production to the House Oversight Committee, likely related to financial investigations.
HOUSE_OVERSIGHT_024819.jpg
A Cowen equity research report titled 'Cowen's Collective View of CBD - Ahead of the Curve Series,' dated February 25, 2019. The document analyzes the U.S. CBD market, projecting a $16 billion opportunity by 2025, and discusses consumer trends, scientific understanding, and hemp cultivation. The document bears a House Oversight Committee Bates stamp (HOUSE_OVERSIGHT_024819) and a watermark indicating it was intended for Michael Cella at Cowen.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity